Related Experiment Video
Updated: Jun 26, 2026

Protocol for MicroRNA Transfer into Adult Bone Marrow-derived Hematopoietic Stem Cells to Enable Cell Engineering Combined with Magnetic Targeting
Published on: June 18, 2018
Clinical side effects during peripheral blood progenitor cell infusion
Ayhan Donmez1, Murat Tombuloglu, Ayse Gungor
1Ege University Medical School Hospital, Department of Internal Medicine, Division of Hematology, Bornova, 35100 Izmir, Turkey. ayhan.donmez@ege.edu.tr
Side effects during peripheral blood progenitor cell (PBPC) infusions are linked to product volume, DMSO, and TNC content in autologous transplants. Reducing these factors may mitigate infusion-related adverse events.
Area of Science:
- Hematology
- Transplantation Medicine
- Clinical Pharmacology
Background:
- Infusion of peripheral blood progenitor cells (PBPCs) can cause adverse events.
- These side effects may stem from the infusion process or the infusate composition.
Purpose of the Study:
- To evaluate side effects during PBPC infusions.
- To identify factors associated with infusion-related adverse events in autologous and allogeneic transplantations.
Main Methods:
- Retrospective analysis of 194 autologous and 25 allogeneic transplantations.
- Detailed recording of side effects during and after PBPC infusion.
- Statistical comparison of product volume, DMSO, and TNC content between patients with and without side effects.
Main Results:
- 25.25% of autologous PBPC infusions had side effects, with 23.71% occurring during infusion.
- Cardiac side effects (7.73%) necessitated infusion cessation.
- Higher median volume, DMSO, and TNC content were significantly associated with side effects in autologous cryopreserved PBPC infusions.
Conclusions:
- Product volume, DMSO, and TNC content are directly related to clinical side effects in autologous cryopreserved PBPC infusions.
- No infusion-related side effects were observed with allogeneic non-cryopreserved PBPCs.
- Specific infusate parameters influence PBPC infusion safety.
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Differentiation of Common Myeloid Progenitor Cells
Regulation of Hematopoietic Stem Cells
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

